Background/Aims: Iron overload (IO) is accompanied by hepatic inflammation. The chemokine (C-C motif) ligand 2 (CCL2) mediates inflammation, and its overexpression is associated with IO. However, whether IO results in CCL2 overexpression in the liver and the underlying mechanisms are unclear. Methods: We subjected mice to IO by administering intraperitoneal injections of dextran-iron or by feeding mice a 3% dextran-iron diet to observe the effects of IO on miR-122/CCL2 expression through real-time qPCR and Western blot analysis. We also used indicators, including the expression of the inflammatory cytokine, the inflammation score based on H&E staining and the serum content of ALT and AST to evaluate the effects of IO on hepatic inflammation. Meanwhile, we observed the effects of vitamin E on IO-induced hepatic inflammation. In cells, we used 100 μΜ FeSO 4 or 30 μΜ Holo-Tf to produce IO and observed the roles of miR-122 in regulating CCL2 expression by using miR-122 mimics or inhibitors to overexpress or inhibit miR-122. Then, we used a dual-luciferase reporter assay to prove that miR-122 regulates CCL2 expression through direct binding to its complementary sequence in the CCL2 mRNA 3'UTR. Results: IO induces the downregulation of miR-122 and the upregulation of CCL2, as well as inflammatory responses both in vitro and in vivo. Although IO-induced oxidative stress is eliminated by the antioxidant vitamin E, IO-induced hepatic inflammation still exists, which probably can be explained by the fact that vitamin E has no effects on the miR-122/CCL2 pathway. In in vitro experiments, the overexpression and inhibition of miR-122 significantly reduced and increased CCL2 expression, respectively. The dual-luciferase reporter assay indicates that miR-122 binds CCL2 mRNA 3'UTR. Conclusion:
CCL2 is Upregulated by Decreased miR-122 Expression in Iron-Overload-Induced Hepatic Inflammation
Yuxiao Tang mice that received i.p. injection of PBS were designated control mice, and mice that received i.p. injection of dextran-iron at 200 mg/kg were designated iron-overload (IO) mice. The injections were performed twice per week. For the iron-rich diet experiment, 12 mice were divided into 2 groups: control and 3% dextraniron diet. Mice in the control group were fed a cereal-based diet containing adequate iron, and mice in the 3% dextran-iron diet group were fed 3% dextran-iron for one month. For the vehicle experiment, i.p. injection with an equivalent amount of dextran was used as a negative control. As a substitution vehicle of dextran iron, we i.p. injected sucrose-iron containing an equivalent amount of iron as a positive control. Mice also received i.p. injection twice a week for 4 weeks at a concentration of 200 mg/kg. Vitamin E, dextran, dextran iron and sucrose iron were purchased from Sigma-Aldrich, USA. Corn oil was produced from the China Oil & Foodstuffs Corporation (Shanghai, China).
Detection of hepatic indicators of oxidative stress damage
For detection of the ROS content, first liver tissue was homogenized and centrifuged to obtain the supernatant. Then, we incubated the supernatant with the ROS detection probe DCF (5 μM) at 37℃ in the dark for 1 h. We used a microplate reader to record the fluorescence intensity of the samples. For detection of the SOD activity and the MDA and GSH contents, detection kits were purchased from Jianchen Biotech, Nanjing, China, and all operations strictly followed the manual instructions. For detection of 8-OHdG, we used immunofluorescence to detect the 8-OHdG content in the liver. Anti-8-OHdG was purchased from Abcam, UK.
Cell cultures and chemicals
Huh7 cells were purchased from Zhongqiaoxinzhou Biotech Inc. (Shanghai, China) and treated as described previously [14, 15] . Cells were grown in high-glucose DMEM medium with 10% fetal bovine serum, 100 IU/ml penicillin, and 50 μg/ml streptomycin sulphate. All medium, supplements, and Dulbecco's phosphate-buffered saline for cell culture were purchased from HyClone, USA. FeSO 4 was purchased from Sigma-Aldrich, USA. Apo-transferrin (apo-Tf) and holo-transferrin (holo-Tf) were purchased from Merck Millipore, Germany. Both the transferrin preparations were absent of LPS, as indicated by the Limulus amebocyte lysate assays, for which the rapid Endotoxin detection kit Pyrosate was purchased from ACC, Inc., U.S.A. The miR-122 inhibitor and miR-122 mimics were purchased from RiboBio, Guangzhou, China.
Cell viability and intracellular iron detection
Cell viability was determined by the CCK8 assay (Beyotime Biotechnology, Nantong, China). For detection of the intracellular iron, we used a fluorescence quenching method with the Phen Green TM FL reagent (Thermo Fisher, US), following the manufacturer's instructions. Quenched fluorescence meant that iron ions were permeated into the cells.
Transfection in vitro
Cell transfection was performed by lipofectamine RNAiMAX (for miRNA inhibitors and mimics) or by lipofectamine 3000 (for plasmids), according to the manufacturer's instructions [16] . We transfected cells with miR-122 mimics at a concentration of 50 mM and miR-122 inhibitors at a concentration of 100 mM. Cells were harvested for the downstream experiments, such as qRT-PCR and Western blot analysis, at 48 h post-transfection.
Dual-Luciferase Reporter Assay
Plasmids of GP-miRGLO (Genepharma, Shanghai, China) containing either the wild-type or mutated CCL2 mRNA 3'UTR were co-transfected with miR-122 mimics or negative control in Huh7 cells. Forty-eight hours after transfection, the cells were lysed for luciferase activity with a Dual-Luciferase® Reporter Assay System (Promega, Mannheim, Germany), and firefly luciferase activity was normalized to Renilla luciferase activity.
Western Blot Analysis
Western blot assays were performed as previously described [17] , with modification. Briefly, the Total Protein Extraction Kit (KeyGEN BioTECH, Nanjing, China)was used to extract total protein from the mice tissues and cultured cells. Following normalization for protein concentration by using BCA kits (Thermo Fischer, US), the samples were separated using 12% SDS-PAGE electrophoresis, electrotransferred to a nitrocellulose membrane and probed with relevant primary antibodies at 4°C overnight: CCL2 antibodies (1:400), p65 antibody (1:1000), IκBα antibody (1:1000), p-IκBα antibody (1:1000), TNFα (1:1000), IL-6 (1:1000) and β-actin antibody (1:3000). All antibodies were purchased from Cell Signaling Technology, USA; Protech, USA; or Santa Cruz, USA. Greyscale image data using GeneSnap from the SynGene software package were normalized to the β-actin abundance.
Quantitative Real-time PCR Analysis
Total RNA from the liver tissues or cells was extracted using TRIzol from Thermo Fisher, USA [18] , and purified using the RNeasy Mini Kit from Qiagen, USA [19] . One microgram of total RNA was reversed-transcribed into cDNA using the RT reagent kit (Takara, Japan) with oligo-dT primers for mRNA or special RT stem-loop primers for microRNA. Mixed cDNA templates, primers, and SYBR green (Toyobo, Japan) reagents were subjected to the Step One Plus real-time system from Thermo Fisher, USA. All primers are listed in Table 1 . The results were normalized to the β-actin (for mRNA) or U6 (for microRNA) abundance.
Iron Status Parameters
The liver iron level was quantitated using an atomic absorption spectrophotometer (Z-8100, Hitachi, Tokyo, Japan) and normalized to the dry tissue weight for each sample. Serum iron concentrations and TIBC in non-haemolysed serum samples were determined by KX-21 automated haematology analyser (Sysmex Co., Japan). The transferring saturation (TS) was calculated as the plasmatic iron/TIBC. 
Statistics
The t-test was used for two-group comparisons, and one-way ANOVA was used for multigroup comparison, if the data obeyed the normal distribution. If the data did not obey the normal distribution, the Mann-Whitney test was used for two-group comparisons, and the Kruskal-Wallis test was used for multigroup comparisons.
Results

IO affects miR-122/CCL2 pathway and triggers inflammatory responses in vivo, which is independent of route of administration and vehicle
Mice were fed a cereal-based diet that contained adequate iron. A subgroup of mice was intraperitoneally injected with dextran-iron and another group was injected with PBS. The liver iron content and serum iron content, as well as other serum iron indicators, such as serum total iron-binding capacity and serum transferrin saturation, were significantly enhanced over time after IO (Table 2) . Prussian-blue-stained liver sections showed normal tissue architecture with little stainable cells in the control group (Fig. 1A) . In contrast, heavy iron a c c u m u l a t i o n was observed not only in the hepatic i n t e r c e l l u l a r space but also inside the hepatocytes 4 weeks after iron administration (Fig. 1A ). These confirmed that mice became overloaded with iron. More importantly, IO led to a time-dependent decrease of miR-122 and a time-dependent increase of the inflammatory genes CCL2, NF-κβ/p65, TNFα, interleukin-6 (IL-6) and interleukin-1beta (IL-1β) (Fig. 1B) . The enhanced protein expression of CCL2, NF-κβ/p65, phosphorylated-IκBα, and TNFα was further confirmed by Western blot assays (Fig. 1C) . In addition, H&E staining revealed that the hepatic IO is associated with increased infiltration of neutrophils and macrophages (Fig.  1D ). Both the hepatic inflammation scores and the serum activities of AST and ALT (Fig. 1E) were significantly increased upon iron administration over time.
To extend our findings to a different animal model of iron administration, a group of mice were fed a 3% dextron-iron containing diet for 1 month and were compared to age-matched animals kept on standard chow. The liver iron content, serum iron content and other serum iron indicators were significantly enhanced (Table 3) , as well as the iron accumulation in the liver, which was shown by Prussian-blue staining ( Fig. 2A) . Meanwhile, immune cell infiltration ( Fig. 2A) , serum transaminases (Fig. 2B, 2C ), the hepatic inflammation score (Fig.  2D) , and the serum content of TNFα and IL-6 (Table 3) were all determined to be significantly increased in iron-fed mice. More meaningfully, those mice displayed significantly elevated mRNA and protein levels of multiple inflammatory genes in the liver tissues ( Fig. 2E and 2F ), while expression of miR-122 was decreased.
Since there is a concern that the vehicle dextran may function as a potential immune modulator, we injected mice with PBS; dextran; dextran-iron; or sucrose-iron, another clinically used form of iron that can be absorbed by the body [20] . Clearly, heavy iron accumulation and infiltration of inflammatory cells can be found only in mouse livers that were injected with iron, but not vehicle controls (Fig. 3A) . Similarly, both hepatic inflammation scores (Fig. 3B ) and serum activities of AST and ALT (Fig. 3C) were elevated in the mice with IO. Most importantly, only IO treatment, regardless of the vehicle, significantly reduced the expression of miR-122 and increased expressions of inflammatory genes (Fig. 3D) .
IO-induced hepatic inflammation cannot be eliminated by antioxidant Vit.E, which may be because Vit.E intervention has no effects on miR-122/CCL2 pathway
Considering that oxidative stress is a well-known mechanism of IO-induced hepatic inflammation, we planned to use the antioxidant Vit.E as an intervention and observe the effects of Vit.E as an anti-inflammatory reagent. For the design of experiment, we established 4 groups: Control, IO, IO+corn oil and IO+Vit.E. Prussian blue staining (Fig. 4A) and quantification of the liver iron content, serum iron content and other serum iron indicators (Table 4) showed that the 3 groups with injection of dextran-iron had significant accumulations of iron in the liver. Meanwhile, IO-induced oxidative stress seems to be eliminated by Vit.E according to the ROS, GSH, MDA and SOD results (Fig. 4C ) and immunofluorescence of 8-hydroxydeoxyguanosine (8-OHdG), a marker of DNA damage induced by oxidative stress (Fig.  4A) .
However, hepatic inflammation, as shown by H&E staining (Fig. 4A) , ALT/AST serum content and the inflammation score (Fig. 4B) were not reversed by administration of Vit.E. In addition, gene expression (Fig. 4D ) and protein expression (Fig. 4E) of the inflammatory factors NF-κβ/ p65, TNFα and IL-6 exhibited the same change. A more meaningful result was that the mir-122/CCL2 pathway was not changed by Vit.E intervention, which may be the reason why Vit.E intervention cannot alleviate IO-induced hepatic inflammation.
Taken together, these in vivo results suggest that hepatic inflammation induced by IO is not merely attributed to oxidative stress damages. Alterations of the miR-122/CCL2 pathway under IO seem to be involved in hepatic inflammation as well.
IO regulates the expression of miR-122/CCL2 and results in significant inflammatory responses in vitro
First, we evaluated the cytotoxicity of FeSO 4 on a human hepatocyte cell line, Huh7. As shown in Fig. 5A , at 24 hours post-exposure, concentrations higher than 100 µM of FeSO 4 have significant effects on cell viability. Since the method of fluorescence signal quenching revealed that 100 µM of FeSO 4 treatment led to dramatic increases of intracellular iron content (Fig. 5B) , in future experiments, this concentration was used to perform in vitro (Fig. 5C ). Finally, it was also evident that FeSO 4 treatment resulted in significantly enhanced CCL2 expression at both the mRNA and protein levels (Fig. 5D) . Next, we investigated whether iron-overload could induce hepatic inflammatory responses in vitro. To this end, we observed enhanced expression of NF-κβ/p65 and other pro-inflammatory cytokines, including TNFα and IL-6 (Fig. 5E ), upon FeSO 4 treatment. Interestingly, the time-dependent assays demonstrated that the reduction of miR-122 occurred as early as 4 hours post-iron overload, followed by an increase in CCL2 that occurred an additional 4 hours later. Lastly, the enhanced expression of NF-κβ/p65 and other pro-inflammatory cytokines was observed at a much later time points, 12 hours and 24 hours post-treatment, respectively. These results suggested that iron overload may first lead to the alteration of miR-122/CCL2 expression, which in turn results in the activation of the NF-κβ signalling pathway and eventually the enhanced expression of the target genes, such as TNFα and IL-6.
Extracellular iron enters cells in the form of either iron ions or holo-Tf through the cellular membrane protein, TfR1. Thus, we also tested the ability of holo-Tf on the miR-122/CCL2 pathway. As shown in Fig. 5F , the treatment of holo-Tf significantly reduced the 
miR-122 expression in both a time-and concentration-dependent manner. In addition, the CCL2 expression was increased by holo-Tf treatment (Fig. 5G) . On the contrary, the negative control, Apo-Tf, had no effect on CCL2 expression. Taken together, our results indicated that iron overload affects the miR-122/CCL2 pathway to induce the hepatic inflammatory response.
miR-122 controls CCL2 expression in vitro
We first investigated the endogenous expression of both miR-122 and CCL2 in various hepatic cell lines. As shown in Fig. 6A , a negative correlation between the abundance of miR-122 and CCL2 mRNA was observed, suggesting that miR-122 may negatively regulate the expression of CCL2. Next, we transfected Huh7 cells with either miR-122 mimics or inhibitors, as described in the Methods section. The results indicated that the overexpression of miR- 122 reduced CCL2 expression at both the mRNA and the protein levels (Fig. 6B) , whilst on the contrary, downregulation of miR-122 had the opposite effect (Fig. 6C) . Furthermore, using the TargetScan online prediction software, we identified a potential miR-122 binding sequence at the 3'-UTR of CCL2 mRNA (Fig. 6D) . Then, this region was subcloned into a GPmiRGLO plasmid carrying a firefly luciferase transgene and a Renilla luciferase transgene as an internal reference. The results of the transfection assays indicated that the WT 3'-UTR of CCL2 mRNA significantly reduced the relative luciferase activity in Huh7 cells. Moreover, coadministration of miR-122 mimics further reduction of the relative luciferase activity. On the contrary, mutant miR122 binding sequence had no effect (Fig. 6D) . To further corroborate our conclusions, we showed that overexpression of miR-122 completely restored the FeSO 4 -induced CCL2 expression back to the normal level (Fig. 6E) . Taken together, our data clearly demonstrated that, in the hepatic cells, CCL2 expression is regulated by the most abundant microRNA in the liver, miR-122.
Discussion
It is generally recognized that iron overload is connected with hepatic inflammation through ROS [21] [22] [23] . In the present study, we show that elimination of oxidative stress by the antioxidant Vit.E cannot remove IO-induced hepatic inflammation. In addition, we demonstrated that the miR-122/CCL2 pathway is influenced by iron overload both in vitro and in vivo and the effects of IO are independent of the route of administration and vehicle. Alterations of the miR-122/CCL2 pathway may account for the inability of Vit.E to alleviate IO-induced hepatic inflammation because Vit.E intervention had no effect on the miR-122/ CCL2 pathway. It has been reported that the intracellular iron content may affect the CCL2 expression in neuroblastoma and astrocytoma cell lines [24] , rat aorta [25] and heart tissues [26] , and mice cardiovascular systems [27] . Otogawa et al. used an acute liver injury model that is induced by thioacetamide [28] . In this case, reduced dietary iron is beneficial in improving the acute liver injuries probably by reducing CCL2 expression. Most importantly, it is observed that in patients with hereditary haemochromatosis, a differential expression of serum CCL2 protein is associated with iron overload [29] . Thus, our observation that IO results in significantly increased CCL2 expression, both in human liver cells lines in vitro and in mice livers in vivo, is consistent with these previous reports.
Furthermore, we investigated the molecular mechanisms underlying the IO-induced CCL2 expression and observed that the reduced expression of miR-122 is associated with IO-induced CCL2 expression. In 2012, two independent groups generated new mice models with liver conditional knockouts of miR-122 [11, 12] . The CCL2 expression in the liver was enhanced in one model but not in the other. Later, another group briefly reported that the decrease of miR-122 may cause an upregulation of CCL2 [30] . In the present study, our data demonstrates that the downregulation of miR-122 mediated the upregulation of CCL2 by directly binding to the 3' UTR of CCL2 mRNA. It is suggested that miRNA biogenesis is partially dependent on the availability of iron-containing haeme [31] . The association with haeme promotes the dimerization of DGCR8. In reconstituted pri-miRNA processing assays, haeme enhances DGCR8 dimerization, a nuclear protein that is involved in the release of the 70-nucleotide precursor-miRNA (pre-miRNA) from the pri-miRNA [32] . However, both studies were conducted in a cell-free system. Further studies will be necessary to investigate how this mechanism influences IO-induced miR-122 deficiency in vivo. Nevertheless, in addition to its direct role in systemic iron homeostasis [13] , several key observations also underscore the importance of miR-122 in liver biology and disease, such as lipid metabolism [33, 34] , cell differentiation [35] , hepatic circadian regulation [36] , HCV replication [37] , and hepatocellular carcinoma [38] . Most of these processes involve alterations in iron homeostasis.
Based on our data, we propose here a model to elucidate the roles of miR-122/CCL2 under IO (Fig. 7) . Serum irons are monitored by a set of cellular proteins, such as TfR1, DMT1, BmpR, HJV and HEF [39] . Accumulation of iron in the liver resulted in elevated hepcidin expression through the BMP-SMAD pathway. Increased systemic hepcidin levels inhibit iron release from macrophages and duodenal enterocytes [40] . In addition, IO results in a significantly reduced expression of miR-122, which increases not only HFE and HJV expression [13] but also CCL2 expression, eventually triggering the NFκB-mediated inflammatory response, such as TNFa, IL-6 and IL-1β expression. In summary, our model and studies should be informative for elucidating the mechanism of IO-induced hepatic inflammation and for developing clinical strategies to prevent diseases in the patients with iron overload. 
